Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Scott, Kenneth L."'
Autor:
Jalali A; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas., Yu K; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Beechar V; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Bosquez Huerta NA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.; Program in Developmental Biology, Baylor College of Medicine, Houston, Texas., Grichuk A; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas., Mehra D; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas., Lozzi B; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Kong K; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Scott KL; Department of Human and Molecular Genetics, Baylor College of Medicine, Houston, Texas., Rao G; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas., Bainbridge MN; Rady Children's Institute of Genomic Medicine, Rady Children's Hospital-San Diego, California., Bondy ML; Department of Epidemiology and Population Health, Stanford University, Palo Alto, California., Deneen B; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas. deneen@bcm.edu.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.; Program in Developmental Biology, Baylor College of Medicine, Houston, Texas.
Publikováno v:
Cancer research [Cancer Res] 2021 May 15; Vol. 81 (10), pp. 2703-2713. Date of Electronic Publication: 2021 Mar 29.
Autor:
Ip CKM; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. ckip@bsd.uchicago.edu., Ng PKS; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Jeong KJ; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Shao SH; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Ju Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Leonard PG; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, TX, 77054, USA.; Core for Biomolecular Structure and Function, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1881 East Road, Houston, TX, 77054, USA., Hua X; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Vellano CP; Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Woessner R; Cancer Bioscience, in vivo Cancer Pharmacology, AstraZeneca Phamaceuticals, Boston, MA, 02451, USA., Sahni N; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1808 Park Rd 1C, Smithville, TX, 78957, USA., Scott KL; Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Suite 450A, Houston, TX, 77030, USA., Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.
Publikováno v:
Nature communications [Nat Commun] 2018 Nov 02; Vol. 9 (1), pp. 4583. Date of Electronic Publication: 2018 Nov 02.
Autor:
Wang Z; Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.; Institute for Personalized Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Ng KS; Institute for Personalized Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Chen T; Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Kim TB; Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Wang F; Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Shaw K; Institute for Personalized Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Scott KL; Department of Human and Molecular Genetics, Baylor College of Medicine, Houston, Texas, United States of America., Meric-Bernstam F; Institute for Personalized Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.; Department of Investigational Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Mills GB; Institute for Personalized Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America., Chen K; Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.; Institute for Personalized Cancer Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America.
Publikováno v:
PloS one [PLoS One] 2018 May 08; Vol. 13 (5), pp. e0196939. Date of Electronic Publication: 2018 May 08 (Print Publication: 2018).
Autor:
Ng PK; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jeong KJ; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shao S; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX 77030, USA., Tsang YH; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Sengupta S; Division of Oncology, Department of Medicine, Washington University, St. Louis, MO 63108, USA., Wang Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bhavana VH; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Tran R; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Soewito S; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Minussi DC; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Moreno D; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Kong K; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Dogruluk T; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Lu H; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Gao J; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Tokheim C; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD 21218, USA., Zhou DC; Division of Oncology, Department of Medicine, Washington University, St. Louis, MO 63108, USA., Johnson AM; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zeng J; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ip CKM; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ju Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wester M; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yu S; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li Y; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vellano CP; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Schultz N; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Karchin R; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA; Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD 21218, USA; Department of Oncology, Johns Hopkins Medicine, Baltimore, MD 21287, USA., Ding L; Division of Oncology, Department of Medicine, Washington University, St. Louis, MO 63108, USA; Siteman Cancer Center, Washington University, St. Louis, MO 63108, USA., Lu Y; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Cheung LWT; HKU Shenzhen Institute of Research and Innovation, Shenzhen, China; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR., Chen K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Meric-Bernstam F; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Scott KL; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Yi S; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: syi2@mdanderson.org., Sahni N; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: nsahni@mdanderson.org., Liang H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: hliang1@mdanderson.org., Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Cancer cell [Cancer Cell] 2018 Mar 12; Vol. 33 (3), pp. 450-462.e10.
Autor:
Sun C; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. csun5@mdanderson.org.; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China., Fang Y; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yin J; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen J; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of General Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Province, Hangzhou 310000, China., Ju Z; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang D; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen X; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vellano CP; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jeong KJ; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ng PK; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Eterovic AKB; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Bhola NH; Provost Office, University of California, San Francisco, San Francisco, CA 94158, USA., Lu Y; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Grandis JR; Provost Office, University of California, San Francisco, San Francisco, CA 94158, USA., Lin SY; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Scott KL; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Peng G; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Brugge J; Department of Cell Biology, Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA., Mills GB; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2017 May 31; Vol. 9 (392).
Autor:
Yang L; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA., Lee MS; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul 06351, Korea., Lu H; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Oh DY; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul 06351, Korea., Kim YJ; Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea; Samsung Biomedical Research Institute, Samsung Advanced Institute of Technology (SAIT), Samsung Electronics Co., Seoul 06351, Korea., Park D; Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea; Samsung Biomedical Research Institute, Samsung Advanced Institute of Technology (SAIT), Samsung Electronics Co., Seoul 06351, Korea., Park G; Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea., Ren X; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Bristow CA; Department of Genomic Medicine and Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Haseley PS; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Lee S; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA., Pantazi A; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Kucherlapati R; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Park WY; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul 06351, Korea; Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea., Scott KL; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Choi YL; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul 06351, Korea; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea. Electronic address: ylachoi@skku.edu., Park PJ; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA; Ludwig Center, Harvard Medical School, Boston, MA 02115, USA. Electronic address: peter_park@harvard.edu.
Publikováno v:
American journal of human genetics [Am J Hum Genet] 2016 May 05; Vol. 98 (5), pp. 843-856.
Autor:
Bonnen PE; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA. pbonnen@bcm.edu, Yarham JW, Besse A, Wu P, Faqeih EA, Al-Asmari AM, Saleh MA, Eyaid W, Hadeel A, He L, Smith F, Yau S, Simcox EM, Miwa S, Donti T, Abu-Amero KK, Wong LJ, Craigen WJ, Graham BH, Scott KL, McFarland R, Taylor RW
Publikováno v:
American journal of human genetics [Am J Hum Genet] 2013 Sep 05; Vol. 93 (3), pp. 471-81. Date of Electronic Publication: 2013 Aug 29.
Autor:
Sun, Chaoyang, Fang, Yong, Yin, Jun, Chen, Jian, Ju, Zhenlin, Zhang, Dong, Chen, Xiaohua, Vellano, Christopher P, Jeong, Kang Jin, Ng, Patrick Kwok-Shing, Eterovic, Agda Karina B, Bhola, Neil H, Lu, Yiling, Westin, Shannon N, Grandis, Jennifer R, Lin, Shiaw-Yih, Scott, Kenneth L, Peng, Guang, Brugge, Joan, Mills, Gordon B
Publikováno v:
Science translational medicine, vol 9, iss 392
Mutant RAS has remained recalcitrant to targeted therapy efforts. We demonstrate that combined treatment with poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors and mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitors evokes u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::178aa845aef29eb9319de95287a53ec5
https://escholarship.org/uc/item/9gg039w6
https://escholarship.org/uc/item/9gg039w6